P1. Potential for use of [C-14]2DG as a predictor of [F-18]FDG tumour distribution for assessment of therapeutic efficacy.

Autor: Dearling, J. L.J., Flynn, A. A., Watson, R. J., Boxer, G. M., Sutcliffe-Goulden, J., Boden, R., Begent, R. H.J., Pedley, R. B.
Zdroj: Nuclear Medicine Communications; Apr2000, Vol. 21 Issue 4, p394-395, 2p
Databáze: Complementary Index